Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.67 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.59 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.57 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.57 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.57 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.57 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.57 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.57 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.57 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.57 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.57 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.57 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.57 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.57 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.57 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9664715 | 1.00 | FAAH (0.67) | FAAHPSMB5PTPN1HDAC3HDAC4 | |
| SCHEMBL5200203 | 1.00 | FAAH (0.67) | FAAHPSMB5PTPN1HDAC3HDAC4 | |
| SCHEMBL9666046 | 1.00 | FAAH (0.67) | FAAHPSMB5PTPN1HDAC3HDAC4 | |
| SCHEMBL9664236 | 1.00 | FAAH (0.67) | FAAHPSMB5PTPN1HDAC3HDAC4 | |
| SCHEMBL9666189 | 1.00 | FAAH (0.67) | FAAHPSMB5PTPN1HDAC3HDAC4 | |
| SCHEMBL9666396 | 0.99 | FAAH (0.65) | FAAHPSMB5PTPN1HDAC3HDAC4 | |
| SCHEMBL3147995 | 0.94 | PSMB5 (0.60) | FAAHPSMB5PTPN1HDAC3HDAC4 | |
| SCHEMBL23210005 | 0.93 | FAAH (0.76) | FAAHPSMB5PTPN1HDAC3HDAC4 | |
| SCHEMBL18797414 | 0.93 | FAAH (0.76) | FAAHPSMB5PTPN1HDAC3HDAC4 | |
| SCHEMBL19650462 | 0.90 | FAAH (0.59) | FAAHPSMB5PTPN1HDAC3HDAC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1304999-B1 | ANTIPERSPIRANT FORMULATIONS | UNILEVER PLC (GB) | 2007-08-15 | — | — | EP | disclosed |
| US-20070116662-A1 | Antiperspirant/deodorant compositions | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-05-24 | — | — | US | disclosed |
| WO-2007058735-A1 | ANTIPERSPIRANT/DEODORANT COMPOSITIONS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-05-24 | — | — | WO | disclosed |
| EP-1304999-A1 | ANTIPERSPIRANT FORMULATIONS | UNILEVER PLC (GB) | 2003-05-02 | — | — | EP | disclosed |
| US-20020039563-A1 | Antiperspirant formulations | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC | 2002-04-04 | — | — | US | disclosed |
| US-6361766-B1 | ANHYDROUS FORMULATION COMPRISING PARTICULATE ANTIPERSPIRANT SUSPENDED IN WATER-IMMISCIBLE CARRIER FLUID COMPRISING OXYGEN-CONTAINING EMOLLIENT OIL HAVING SPECIFIED REFRACTIVE INDEX STRUCTURED BY WAX OR NONPOLYMERIC FIBER-FORMING GELLANT | UNILEVER HOME & PERSONAL CARE, USA DIVISION OF CONOPCO, INC. | 2002-03-26 | — | — | US | disclosed |
| US-20020034481-A1 | Antiperspirant formulations | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2002-03-21 | — | — | US | disclosed |
| WO-2002011691-A1 | ANTIPERSPIRANT FORMULATIONS | UNILEVER PLC (GB) | 2002-02-14 | — | — | WO | disclosed |
| WO-2002011692-A1 | ANTIPERSPIRANT FORMULATIONS | UNILEVER PLC (GB) | 2002-02-14 | — | — | WO | disclosed |
| US-3969087-A | Gels of nonpolar liquids with N-acyl amino acids and derivatives thereof as gelling agents | AJINOMOTO CO., LTD. (JA) | 1976-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020034481-A1 | Antiperspirant formulations | ADH1A, SOAT1, CUTA | FAAH 43/4885PSMB5 3071/4885PTPN1 1606/4885 |
| US-20070116662-A1 | Antiperspirant/deodorant compositions | PUF60, DDT, DECR1 | FAAH 490/4885PSMB5 965/4885PTPN1 2099/4885 |
| US-20020039563-A1 | Antiperspirant formulations | ADH1A, SOAT1, CUTA | FAAH 58/4885PSMB5 3915/4885PTPN1 1219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.